Syndax Pharmaceuticals SNDX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's EV / sales?
- Syndax Pharmaceuticals (SNDX) reported EV / sales of 10.5× in Q1 2026.
- How has Syndax Pharmaceuticals's EV / sales changed year-over-year?
- Syndax Pharmaceuticals's EV / sales decreased by 63.0% year-over-year, from 28.3× to 10.5×.
- What is the long-term trend for Syndax Pharmaceuticals's EV / sales?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's EV / sales has grown at a -74.5% compound annual growth rate (CAGR), from 715.5× to 11.8×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.